Delamanid-d4

• CAT Number: S000196
• Molecular Formula: C25H21D4F3N4O6
• Molecular Weight: 538.51
• Purity: ≥95%
• Target: Bacterial
• IUPAC Name: (2R)-2-methyl-6-nitro-2-[[2,3,5,6-tetradeuterio-4-[4-[4-(trifluoromethoxy)phenoxy]piperidin-1-yl]phenoxy]methyl]-3H-imidazo[2,1-b][1,3]oxazole
• InChI: InChI=1S/C25H25F3N4O6/c1-24(15-31-14-22(32(33)34)29-23(31)38-24)16-35-18-4-2-17(3-5-18)30-12-10-20(11-13-30)36-19-6-8-21(9-7-19)37-25(26,27)28/h2-9,14,20H,10-13,15-16H2,1H3/t24-/m1/s1/i2D,3D,4D,5D
• InChIKey: XDAOLTSRNUSPPH-HALYWNOZSA-N
• SMILES: [2H]C1=C(C(=C(C(=C1N2CCC(CC2)OC3=CC=C(C=C3)OC(F)(F)F)[2H])[2H])OC[C@]4(CN5C=C(N=C5O4)[N+](=O)[O-])C)[2H]

Delamanid-d4, a premium pharmaceutical research compound designed for advanced tuberculosis and antimicrobial studies. As a deuterated analog of Delamanid, it offers enhanced stability and improved pharmacokinetic properties. Delamanid-d4 is ideal for use in pharmacological and biochemical research, providing precise and reliable data for your studies. This high-purity compound ensures consistent results, aiding in the development of novel therapies for tuberculosis and other infectious diseases. Trusted by leading laboratories, Delamanid-d4 is your go-to solution for cutting-edge antimicrobial research. Unlock new possibilities in infection treatment with Delamanid-d4, where innovation meets reliability.

Reference

[1]. Sotgiu G, et al. Delamanid (OPC-67683) for treatment of multi-drug-resistant tuberculosis. Expert Rev Anti Infect Ther. 2015 Mar;13(3):305-15.
[Content Brief]